Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-25-001324
Filing Date
2025-07-25
Accepted
2025-07-25 16:14:20
Documents
1
Period of Report
2025-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4162
  Complete submission text file 0001640334-25-001324.txt   5912
Mailing Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000
Business Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000 86 (010) 6615-5141
Yubo International Biotech Ltd (Issuer) CIK: 0000895464 (see all company filings)

EIN.: 113074326 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address MAGNA-LAB, INC. ROOM 105, BUILDING 5, 31 XISHIKU AVENUE XICHENG DISTRICT BEIJING China
Business Address
Wang Jun (Reporting) CIK: 0001828246 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21320 | Film No.: 251151839